Assessment of the degree of activity of Crohn’s disease in patients using a specialized scale based on magnetic resonance enterography
https://doi.org/10.29413/ABS.2025-10.6.5
Abstract
Background. Magnetic resonance enterography is increasingly being used to diagnose Crohn’s disease due to its non-invasiveness, absence of ionizing radiation, and high information content. Despite this, there is still no consensus in the international medical community regarding the use of inflammation indices during MR enterography.
The aim. The presented study examines the possibility of using a specialized scale based on magnetic resonance enterography data to assess the degree of disease activity in patients with Crohn’s disease.
Materials and methods. The analysis was conducted on a group of 40 patients with a confirmed diagnosis of Crohn’s disease, whose intestinal tract was evaluated according to the criteria of the specialized scale.
Results. During data processing, it turned out that 24 patients (60.0 %) had a score range of 0 to 7, which indicated remission, 10 (25.0 %) had a score range of 8 to 15 (minimal activity), and 6 (15.0 %) had a score range of 16 or more (severe clinical manifestations).
Conclusion. Thus, the scale we developed for assessing the activity of Crohn’s disease serves as an effective tool for standardizing diagnosis and monitoring patients’ conditions. This method provides an objective assessment of the level of inflammation and the course of the disease.
About the Authors
G. M. ZhargalovaRussian Federation
Galina M. Zhargalova – Graduate Student, Irkutsk Scientific Centre of Surgery and Traumatology; Radiologist at the MRI Department, Irkutsk City Regional Oncological Clinic; assistant of the Department of Radiation and Clinical Laboratory, Irkutsk State Medical Academy of Postgraduate Education – branch of the Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation
Bortsov Revolyutsii str. 1, Irkutsk 664003;
Frunze str., 32, Irkutsk 664035:
Yubileyny Microdistrict, 100, Irkutsk, 664049
P. V. Seliverstov
Russian Federation
Pavel V. Seliverstov – Dr. Sc. (Med.), Leading Research Officer, Head of the Department of Radiodiagostics of the Clinical Research Department of Neurosurgery
Bortsov Revolyutsii str. 1, Irkutsk 664003
References
1. Cockburn E, Kamal S, Chan A, Rao V, Liu T, Huang JY, et al. Crohn’s disease: an update. Clin Med (Lond). 2023; 23(6): 549-557. doi: 10.7861/clinmed.2023-0493
2. Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet. 2024; 403(10432): 1177-1191. doi: 10.1016/S01406736(23)02586-2
3. Richard N, Savoye G, Leboutte M, Amamou A, Ghosh S, Marion-Letellier R. Crohn’s disease: Why the ileum? World J Gastroenterol. 2023; 29(21): 3222-3240. doi: 10.3748/wjg.v29.i21.3222
4. Caruso R, Lo BC, Chen GY, Núñez G. Host-pathobiont interactions in Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2025; 22(6): 395-414. doi: 10.1038/s41575-02400997-y
5. Hornschuh M, Wirthgen E, Wolfien M, Singh KP, Wolkenhauer O, Däbritz J. The role of epigenetic modifications for the pathogenesis of Crohn’s disease. Clin Epigenetics. 2021; 13(1): 108. doi: 10.1186/s13148-021-01089-3
6. Sila S, Hojsak I. Nutritional Management for Crohn’s Disease. Nutrients. 2024; 16(16): 2597. doi: 10.3390/nu16162597
7. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68(Suppl 3): s1-s106. doi: 10.1136/gutjnl-2019-318484
8. De Cruz P, Hamilton AL, Burrell KJ, Gorelik A, Liew D, Kamm MA. Endoscopic Prediction of Crohn’s Disease Postoperative Recurrence. Inflamm Bowel Dis. 2022; 28(5): 680688. doi: 10.1093/ibd/izab134
9. Pal P, Reddy DN, Rao GV. Endoscopic Assessment of Postoperative Recurrence in Crohn’s Disease: Evolving Concepts. Gastrointest Endosc Clin N Am. 2025; 35(1): 121140. doi: 10.1016/j.giec.2024.04.010
10. Rimola J, Torres J, Kumar S, Taylor SA, Kucharzik T. Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease. Gut. 2022;71(12):2587-2597. doi: 10.1136/gutjnl-2021-326562
11. Dal Buono A, Faita F, Armuzzi A, Jairath V, Peyrin-Biroulet L, Danese S, et al. Assessment of activity and severity of inflammatory bowel disease in cross-sectional imaging techniques: a systematic review. J Crohns Colitis. 2025; 19(2): jjaf023. doi: 10.1093/ecco-jcc/jjaf023
12. Minordi LM, D’Angelo FB, Privitera G, Papa A, Larosa L, Laterza L, et al. Crohn’s Disease: Radiological Answers to Clinical Questions and Review of the Literature. J Clin Med. 2024; 13(14): 4145. doi: 10.3390/jcm13144145
13. Cicero G, Mazziotti S. Crohn’s disease at radiological imaging: focus on techniques and intestinal tract. Intest Res. 2021; 19(4): 365-378. doi: 10.5217/ir.2020.00097
14. Gauci J, Sammut L, Sciberras M, Piscopo N, Micallef K, Cortis K, et al. Small bowel imaging in Crohn’s disease patients. Ann Gastroenterol. 2018; 31(4): 395-405. doi: 10.20524/aog.2018.0268
15. Moy MP, Sauk J, Gee MS. The Role of MR Enterography in Assessing Crohn’s Disease Activity and Treatment Response. Gastroenterol Res Pract. 2016; 2016: 8168695. doi: 10.1155/2016/8168695
16. Biondi M, Bicci E, Danti G, Flammia F, Chiti G, Palumbo P, et al. The Role of Magnetic Resonance Enterography in Crohn’s Disease: A Review of Recent Literature. Diagnostics (Basel). 2022; 12(5): 1236. doi: 10.3390/diagnostics12051236
17. Varyani F, Samuel S. Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn’s disease? Best Pract Res Clin Gastroenterol. 2019; 38-39: 101621. doi: 10.1016/j.bpg.2019.05.008
18. Chavoshi M, Mirshahvalad SA, Kasaeian A, Djalalinia S, Kolahdoozan S, Radmard AR. Diagnostic Accuracy of Magnetic Resonance Enterography in the Evaluation of Colonic Abnormalities in Crohn’s Disease: A Systematic Review and Meta-Analysis. Acad Radiol. 2021; 28 Suppl 1: S192-S202. doi: 10.1016/j.acra.2021.02.022
19. D’Amico F, Chateau T, Laurent V, Danese S, Peyrin-Biroulet L. Which MRI Score and Technique should be used for assessing Crohn’s Disease Activity? J Clin Med. 2020; 9(6): 1691. doi: 10.3390/jcm9061691
Review
For citations:
Zhargalova G.M., Seliverstov P.V. Assessment of the degree of activity of Crohn’s disease in patients using a specialized scale based on magnetic resonance enterography. Acta Biomedica Scientifica. 2025;10(6):37-45. (In Russ.) https://doi.org/10.29413/ABS.2025-10.6.5
JATS XML

.png)































